Sat, Feb 28, 2015, 2:22 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • bhukap1116 bhukap1116 Jan 30, 2013 10:39 PM Flag

    clinical trials

    I just tried to put a patient on the Cabo survival trial and learned that according to clinical trials.gov very few centers in NY are actively recruiting and the one center I contacted said they were having trouble recruiting because half the patients on the trial get a useless treatment. I understand the FDA and the company but personally unless there is a crossover after progression the trial will take a long time to accrue. On the other hand it is difficult if not impossible to show a benefit in survival if crossover is allowed. The trial should have been done on earlier patients against something like Jevtana. We are going to have to be super patient to see results in the survival trial

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
EXEL
2.930.000(0.00%)Feb 27 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.